Although commonly available prognostic factors include pathology criteria such as lymph-node status, tumor size, histologic grade and estrogen receptor (ER) status, these factors do not predict accurately exact clinical outcome probably due to heterogeneity of breast cancers. This evidence concerns the gene ESR1 and breast cancer.